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Lung abscesses as a complication of pelvic inflammatory
disease (PID) caused by an intrauterine device (IUD) have
been described previously but are rare. Geddes et al.
reported on a 31-year old woman with an copper IUD who
developed septicemia with lung abscesses and encepha-
lopathy caused by genital tract infection with Staphylo-
coccus aureus. A vaginal swab and culture from the coil
showed a similar antibiogram to that of the S. aureus
cultured from the blood [1]. Systemic infection through the
hematogenic spread of a microorganism caused by an IUD
was previously described, with Actinomyces as the infec-
tious organism [2, 3]. Multiple hepatic abscesses caused by
Streptococcus milleri in association with an intrauterine
device have also been described [4].
We report a case of a patient with multiple lung
abscesses secondary to a uterine empyema caused by an
intrauterine device with S. milleri as the causative agent.
An otherwise healthy, 29-year old woman visited the
emergency room of our hospital with complaints of dysp-
nea and chest pain. The week before presentation she had
flu-like symptoms with fever, a nonproductive cough and
myalgia. Since then she experienced shortness of breath,
Fig. 3 Computed tomography of the abdomen showing an empyema
in the cavum uteri
Figs. 1, 2 Computed
tomography of the thorax
showing consolidations in the
lung parenchyma with some
cavitation, leading to a
suspicion of abscesses
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orthopnea, and a sharp right-sided chest pain that worsened
on breathing. She had an administrative job and smoked
ten cigarettes a day. There were no known allergies aside
from hayfever. She had not been abroad, had no pets, and
no known tuberculosis contacts. There were no complaints
of weight loss, joint pains, skin lesions or night sweats.
Nobody in the community was sick.
The patient did not appear ill on physical examination.
Blood pressure was 119/70 mmHg, pulse was 106 beats/
min, oxygen saturation was 99% with room air, and tem-
perature was 37.2C (99.0F). She had no lymphadenopa-
thy and no signs of gingivitis. Cardiac examination
revealed no heart murmurs, and breath sounds were normal
without wheezing or rhonchi. Palpation and percussion of
the thorax was not painful and was unremarkable. Exam-
ination of the abdomen and extremities showed no abnor-
malities. A pelvic exam was not performed.
Laboratory findings showed a CRP of 150 mg/l (normal
0–10 mg/l), leukocytosis 29 9 109/L (normal 4–10 9 109/L),
hemoglobin 6.9 mmol/L (normal 7.5–10 mmol/L), and a
platelet count of 735 9 109/L (normal 150–400 9 109/L).
Creatinine, BUN, electrolytes and liver function tests were
within their normal ranges. A chest radiograph taken on
admission showed bilateral diffuse small consolidations
and a small amount of pleural effusion on the right side.
CT scan of the thorax showed consolidations in the lung
parenchyma with some cavitation, leading to a suspicion of
abscesses (see Figs. 1, 2). Blood cultures were taken and
the patient was hospitalized. Bronchoscopy showed no
endobronchial abnormalities. Gram stain of the bronchial
secretion showed Gram-negative rods and Gram-positive
rods and cocci. Because the patient developed fever, broad
spectrum antibiotics (amoxicillin/clavulanic acid) were
started. A transthoracic echocardiogram (TTE) showed no
vegetations on the cardiac valves. Further anamnesis
revealed that she had a faint pain in her lower abdomen and
had experienced an increase in vaginal discharge for some
time. She reported that she had an intrauterine device in
situ for at least 9 years. A CT scan of the abdomen was
made. An empyema was visible in the cavum uteri with the
IUD still in place (see Fig. 3). The gynaecologist was
consulted and transcervical curettage with removal of the
IUD was performed. Macroscopically there was purulent
discharge with necrosis. Finally, the blood cultures
revealed Streptococcus intermedius (milleri group), and the
genital cultures and bronchial secretions revealed Strepto-
coccus milleri. Antibiotics were switched to amoxicillin.
A PCR performed on a genital smear revealed the presence
of Chlamydia trachomatis DNA. A new CT scan of the
thorax and abdomen was performed. There were no other
infectious or venous thromboembolic foci in the abdomen,
and the intrapulmonary abscesses had not changed. The
patient was discharged from hospital, and the antibiotics
were continued for a total of 4 weeks. After 6 weeks, at a
control visit, the patient had recovered completely, and a
control chest X-ray showed no infiltrative lesions.
Lung abscesses mostly occur as a complication of aspira-
tion pneumonia, especially in patients with compromised
consciousness, dysphagia or periodontal diseases like gingi-
vitis [5, 6]. Bacteria are the most common pathogens—usually
anaerobes found in the gingival crevices [6–8].
The most common aerobic bacteria that cause lung
abscesses are S. milleri [9, 10].
The Streptococcus milleri group refers to a heteroge-
neous group of streptococci that consist of Streptococcus
anginosus, Streptococcus constellatus and Streptococcus
intermedius [9, 10]. They are widely distributed commen-
sals, and are normally found in the mouth, upper respira-
tory tract, gastrointestinal tract and vagina [9, 11]. They are
not only a well-known cause of lung abscesses and
empyema; they cause similar lesions at other sites too. It is
considered rare for them to spread to the lungs from the
vagina [9]. A pulmonary infection with this microorganism
may result in considerable morbidity and mortality [9].
Clinical manifestations of a pulmonary infection with
S. milleri can range from indolent disease to rapid onset
and progression with severe toxic symptoms [9].
Modern intrauterine devices cause little, if any,
increased risk for PID. Pelvic inflammatory disease due to
an intrauterine device is most strongly associated with the
insertion process and with the patient’s risk of acquiring a
sexually transmitted disease (STD) [12].
The risk of infection is greatest in the first three weeks
after insertion, and is uncommon thereafter [12–14], and
does not increase with prolonged IUD use [12]. However,
IUDs which have been in the uterus for a prolonged time
have been associated with pelvic actinomycosis [15].
Ninety percent of patients with lung abscesses can be
cured using antibiotics [16]. However, mortality rates are
about 75% in patients with underlying disease [17].
To our knowledge there has never been a report on a
case of lung abscesses due to distant hematogenic spread
from an IUD-related uterine empyema with S. milleri. This
case illustrates that taking the patient’s history and a review
of systems is an important medical tool, and remains the
cornerstone of practice.
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